Evidence map›Paper›PMID 26223355›Full record

ArticleJournal of orthopaedic surgery and research2015

Are biological agents toxic to human chondrocytes and osteocytes?

Mehmet Isyar, Bulent Bilir, Ibrahim Yilmaz, Selami Cakmak, Duygu Yasar Sirin, Aliye Yildirim Guzelant, Mahir Mahirogullari

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Mehmet IsyarDepartment of Orthopaedic and Traumatology, School of Medicine, Istanbul Medipol University, Bagcilar, 34214, Istanbul, Turkey. misyar2003@yahoo.com.
Bulent BilirDepartment of Internal Medicine, School of Medicine, Namik Kemal University, 59100, Tekirdag, Turkey. bulentbilir@yahoo.com.
Ibrahim YilmazDepartment of Pharmacovigilance and Rational Drug Use Team, Republic of Turkey, Ministry of Health, State Hospital, 59100, Tekirdag, Turkey. ibrahimyilmaz77@yahoo.com.
Selami CakmakDepartment of Orthopaedic and Traumatology, Haydarpasa Training Hospital, Gulhane Military Medical Academy, 34668, Istanbul, Turkey. selamcakmak@yahoo.com.
Duygu Yasar SirinFaculty of Science, Department of Molecular Biology and Genetics, Namik Kemal University, 59100, Tekirdag, Turkey. duygusirin@nku.edu.tr.
Aliye Yildirim GuzelantDepartment of Physical Medicine and Rehabilitation, School of Medicine, Namik Kemal University, 59100, Tekirdag, Turkey. aliyeguzelant@gmail.com.
Mahir MahirogullariDepartment of Orthopaedic and Traumatology, School of Medicine, Istanbul Medipol University, Bagcilar, 34214, Istanbul, Turkey. mahirogullari@yahoo.com.
Namık Kemal University · TRIstanbul Medipol University · TRMilitary Medical Academy · RSMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the present study is to investigate the effects of biological agents (BAs) on human chondrocytes and osteocytes in vitro.

methodsPrimary cell cultures obtained from gonarthrosis patients were divided into four groups, two of which were designated as control cultures of chondrocyte and osteocyte, and the other two groups were exposed to BAs administered via the culture medium. Cultured cells were characterized by immunophenotyping. Before and after administration of the agents, the cultures were observed by inverted and environmental scanning electron microscopy (ESEM). The number of live cells and the proliferation rate were monitored by MTT assay.

resultsRituximab and adalimumab were the least toxic agents to chondrocytes, whereas adalimumab and etanercept were to osteocytes.

conclusionDuring periods of intense active inflammation, the concentration of the preferred BAs after inhibition of inflammation needs to be emphasized when their effects on cartilage and bone tissue are considered at the cellular level if the clinical practice is to continue.

Indexed as

AdalimumabAgedBiological FactorsCells, CulturedCell SurvivalChondrocytesFemaleHumansMaleMiddle AgedOsteocytesRituximabAdalimumabBiological FactorsRituximab

Identifiers

PMID26223355
PMCPMC4520184
OpenAlexW2099167483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.